Randomised controlled trial of meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp. (2014–2015)

Grant type:
Australian Society for Antimicrobials
Funded by:
Australian Society for Antimicrobials